Genetic
Approximately 400 BCE — Hippocratic corpus, ancient Greece
Ehlers-Danlos syndrome was a condition that puzzled physicians for centuries before receiving a formal name, as healers historically observed individuals with unusually flexible joints and fragile, elastic skin without understanding the underlying mechanism. Early medical thinkers attributed these traits to constitutional weakness or nervous system irregularities rather than any heritable structural defect. The syndrome was eventually named in the early twentieth century after two dermatologists whose systematic observations helped consolidate what had previously been scattered clinical curiosities into a recognized medical entity.
Historical Narrative
The earliest documented observations resembling what would later be called Ehlers-Danlos syndrome appeared in ancient Greek medical writings, where authors described individuals capable of extraordinary joint mobility, sometimes performing feats that drew public attention. Hippocratic physicians recorded instances of people whose limbs could be manipulated into unusual positions without apparent immediate harm, though these accounts were embedded in broader discussions of constitutional temperament rather than treated as a distinct pathological category. Ancient healers generally interpreted such flexibility as a sign of a particular bodily humoral balance rather than a discrete condition.
During the medieval period, European physicians working within the Galenic tradition continued to frame unusual joint laxity and skin fragility as humoral imbalances, often attributing them to an excess of phlegm or a weakness of the vital spirits thought to animate the connective tissues. Arabian physicians of the Islamic Golden Age, including Avicenna, catalogued a range of musculoskeletal anomalies in their encyclopedic medical texts, though no writer of that era isolated joint hypermobility and skin extensibility as a unified syndrome requiring its own explanatory framework.
The early modern period brought more systematic anatomical investigation, and physicians began documenting individual cases with greater clinical precision. In 1657, the Dutch surgeon Job van Meekeren described a Spanish patient who could stretch the skin of his chin to cover his face and extend the skin of his chest to extraordinary lengths. Van Meekeren presented this case as a marvel of natural variation rather than a disease, and it circulated widely in European medical literature as an anatomical curiosity. This account is now regarded as one of the earliest detailed clinical descriptions consistent with the syndrome.
In the late nineteenth century, dermatologists began approaching such cases with increasing scientific rigor. The Russian physician Alexei Tschernogbow presented a detailed clinical paper in 1891 describing patients with hyperextensible skin and hypermobile joints, recognizing commonalities across multiple individuals and suggesting a systemic underlying cause. His work, though influential within Russian medical circles, did not immediately reshape international medical thinking.
The syndrome gained its lasting eponym through the independent work of two European dermatologists in the early twentieth century. Edvard Ehlers, a Danish physician, published observations in 1901 describing patients with joint laxity and skin that bruised and tore with unusual ease. Henri-Alexandre Danlos, a French dermatologist, contributed further observations in 1908, examining the elastic and fragile qualities of affected skin with particular attention to texture and wound behavior. Medical convention eventually combined their names to designate the condition, formalizing it as a recognized clinical entity.
For much of the mid-twentieth century, physicians classified all such patients under a single diagnostic umbrella, and the heterogeneity of presentations was attributed to varying severity rather than distinct subtypes. Researchers through the latter half of the twentieth century began examining connective tissue biochemistry and identified that different inherited defects in collagen and related proteins produced overlapping but distinct clinical pictures. This work gradually led medical bodies to propose formal classification schemes that divided the syndrome into multiple subtypes based on underlying mechanisms, transforming what had once been a single curiosity into a family of related heritable conditions.
Key Historical Figures
Historical narrative only — this page describes how Ehlers–Danlos syndrome was understood historically. It is not medical advice and does not describe current diagnosis or treatment. Sourced from verified medical history references (NIH, Encyclopaedia Britannica, and standard medical history texts). See our medical disclaimer.